Haemonetics Corporation Shares Outstanding 2009–2026
Haemonetics Corporation reported 45.3M of shares outstanding for fiscal 2026. That was 6.1% lower than fiscal 2025. Compared with fiscal 2021, the change was -11.0%. A falling share count is consistent with net buybacks exceeding issuance over the period, though the filing should be checked for the components.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2026 | 45.3M | -6.1% |
| FY 2025 | 48.2M | -5.1% |
| FY 2024 | 50.8M | +0.7% |
| FY 2023 | 50.4M | -1.3% |
| FY 2022 | 51.1M | +0.5% |
| FY 2021 | 50.9M | +1.1% |
| FY 2020 | 50.3M | -1.4% |
| FY 2019 | 51.0M | -2.5% |
| FY 2018 | 52.3M | +0.2% |
| FY 2017 | 52.3M | +2.6% |
| FY 2016 | 50.9M | -1.4% |
| FY 2015 | 51.7M | -0.7% |
| FY 2014 | 52.0M | +2.0% |
| FY 2013 | 51.0M | +0.8% |
| FY 2012 | 50.6M | +0.0% |
| FY 2011 | 50.6M | -0.5% |
| FY 2010 | 50.9M | — |
| FY 2009 | 0.0M | — |
Source: Haemonetics Corporation SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HAE 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Haemonetics Corporation reported 45.3M of shares outstanding for fiscal 2026. That was 6.1% lower than fiscal 2025. Compared with fiscal 2021, the change was -11.0%. A falling share count is consistent with net buybacks exceeding issuance over the period, though the filing should be checked for the components. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's shares outstanding?
Haemonetics Corporation (HAE) reported shares outstanding of 45.3M for fiscal year 2026, per its SEC filings.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More HAE financial history
Full HAE fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →